EDN1 and bone cancer: ET-1 is upregulated in animal models of cancer-induced hyperalgesia and allodynia,65,72,86 and antagonists selective for the ET-1 receptor, ETA, were shown to attenuate cancer pain in mice66,72,86 and humans.14 ET-1 has also been shown to contribute to peripheral sensitization in murine bone cancer models.